November 09, 2010 10:26
NPERC, Bayer to conduct joint research on biodegradable injection
Shanghai. November 9. INTERFAX-CHINA - The National Pharmaceutical Engineering Research Center (NPERC), a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI), has signed an agreement with German giant Bayer Schering Pharma AG to conduct joint research on a biodegradable injection drug delivery system, SIPI announced Nov. 8.
The announcement did not disclose the financial terms of the agreement.
NPERC is currently working on 10 different technologies for dosage preparation and drug delivery, including biodegradable microspheres, liposome preparations, a bioadhesive dosage form and an oral suspension sustained release system.
May 06, 2016
Putin backs Abe's idea of holding Russian-Japanese, Japanese-Russian bilateral year in 2018
Russian, Jordanian foreign ministers discuss Syria, Palestinian-Israeli conflict
MOSCOW SEES GEORGIAN TERRITORY'S GRADUAL 'TAKEOVER' BY NATO SERVICEMEN AS PROVOCATIVE STEP AIMED AT DESTABILIZING SITUATION IN SOUTH CAUCASUS - RUSSIAN FOREIGN MINISTRY
Lavrov: Putin, Abe didn't discuss sanctions
Russian, Japanese deputy foreign ministers to hold consultations on peace treaty in June - Lavrov
Putin tells Abe: Implementation of Minsk Agreements hindered by Kyiv's inability to fulfill obligations - Lavrov
Putin, Abe discuss situation in Syria, Moscow backs Japan's joining ISSG humanitarian task force - Lavrov
Russia objects to taking advantage of N. Korea's reckless nuclear aspirations to disproportionately step up military presence in region - Lavrov
Russia suggests Japanese border guards take part in drills to fight smuggling in Pacific Ocean this summer
Lavrov: We need legal guarantees that plans for missile defense deployment in Southeast Asia not targeted against Russia
Russian stock market follows Wall Street down, oil cushions drop
Results of Interregional Trading for OFZ & OBR
Capitalization of Russian stock market decreases 0.72% on Friday